We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Court Overrules PTO, Zetia Claims Called Invalid
Federal Court Overrules PTO, Zetia Claims Called Invalid
April 23, 2010
A federal court has ruled certain claims on a patent for Schering-Plough’s cholesterol treatment Zetia are invalid, despite a U.S. Patent and Trademark Office (PTO) decision — which may help Glenmark Pharmaceuticals win approval for a generic version of the drug.